Skip to main content
LKFTLakefront BiotherapeuticsHold6.2·$30.39+2.67%
LKFT · Why this verdict

Why Lakefront Biotherapeutics (LKFT) is rated HOLD

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictHOLD
Overall score6.2/10
ConfidenceMEDIUM
MacroNEUTRAL

Per-dimension breakdown

Value

9.5/10data confidence 40%
ComponentSub-score
P/E10.0
P/S9.0
  • Attractively valued

Quality

6.3/10data confidence 100%
ComponentSub-score
ROE5.4
ROA7.1
Gross margin9.7
Net margin10.0
Current ratio5.0
FCF quality3.5
Moat6.6
Rule of 403.0
Piotroski F6.7
  • Strong margins: 47%
  • Earnings quality RED FLAG: 43% FCF/NI
  • Rule of 40: -71 (fail)

Growth

5.0/10data confidence 50%

Momentum

6.4/10data confidence 100%
ComponentSub-score
RSI3.3
MACD9.9
OBV10.0
MA position6.0
Volume2.7
  • Volume accumulation (rising OBV)
  • Below 200-MA, MA slope -1.8%/30d — confirmed downtrend

Sentiment

4.4/10data confidence 100%
ComponentSub-score
LLM sentiment6.0
Analyst rating5.0
Price target1.9
  • Below analyst target

Insider

5.0/10data confidence 50%

Peer rank

6.7/10data confidence 80%
ComponentSub-score
value rank9.2
quality rank8.7
growth rank0.4
  • Attractive P/E vs peers
  • Superior ROE vs peers

Technical

2.9/10data confidence 100%
ComponentSub-score
bollinger0.0
support resistance0.3
52w position6.1
gap5.0

Risk (lower is worse)

6.5/10data confidence 100%
ComponentSub-score
short interest7.3
days to cover0.0
volatility7.0
put call10.0
implied vol2.3
beta10.0
debt equity9.2
  • High IV: 66%

Catalyst

6.3/10data confidence 100%
ComponentSub-score
erm5.0
earnings history6.7
earnings timing5.0
surprise avg10.0
news activity5.0
  • Strong earnings: 3B/1M

How the verdict was assembled

Engine trigger

Maintain position. Not compelling to add more.

Engine technical detail
verdict_path: L4:PATH_F_HOLD
Passed (7)
  • MOMENTUM:6.4>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:37d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-3.8=NEGATIVE
Warning (1)
  • DEATH_CROSS:momentum=6.4>=5.0 recovering
Reward-to-Risk
-3.76
Upside
-35.7%
Downside
9.5%
Sizing output
AVOID

SetupRecovery Death cross but MACD improving, RSI 67

EdgeInst Constrain Small cap ($2.0B) below institutional reach

SuitabilitySpeculative Binary industry: Biotechnology

Investment implication

None of the engine's positive-conviction paths (C-quality, D-momentum) triggered — the F-path HOLD reflects balanced signals. Strongest-cleared gate: MOMENTUM:6.4>=5.5. Top dim: Value at 9.5; weakest: Technical at 2.9. No conviction either direction.

The strongest dimensions are Value at 9.5, Peer rank at 6.7, and Risk (lower is worse) at 6.5; the weakest are Technical at 2.9, Sentiment at 4.4, and Insider at 5.0. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -3.76 and an engine sizing output of AVOID.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks LKFT Why this verdict